Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
Published . Updated .
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.
Directly affected
- MRNA Moderna
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.
Source: MarketWatch
This story
12 out of 100
“Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.” scores 12 out of 100. The score uses 1 sources.